Exhibit 99.1

FOR IMMEDIATE RELEASE



INTRICON 2007 THIRD-QUARTER SALES UP 48 PERCENT OVER PRIOR YEAR

Focus on Body-Worn Devices Helps Drive Gains



ST. PAUL, Minn.  Oct. 24, 2007  IntriCon Corporation (AMEX: IIN), a designer, developer, manufacturer and distributor of body-worn medical and electronics devices, today announced financial results for its 2007 third quarter ended September 30, 2007.

For the third quarter, the company reported quarterly net sales of $18.4 million, a 48 percent increase from net sales of $12.5 million for the 2006 third quarter. IntriCon delivered third-quarter net income of $650,000, or $0.12 per diluted share, up 48 percent from net income of $438,000, or $0.08 per diluted share, for the 2006 third quarter. The 2007 net sales and net income include results from the late-May 2007 acquisition of Tibbetts Industries, Inc.

Our core businesses of medical, hearing health and professional audiobeing driven by the demand for miniature body-worn devicesposted significant year-over-year gains, said Mark S. Gorder, president and chief executive officer of IntriCon. Medical was particularly strong, growing 137 percent year over year. In the medical arena, were seeing increased demand from OEMs.

For the nine-month period, IntriCon reported net sales of $50.0 million and net income of $1.2 million, or $0.22 per diluted share. This compares to 2006 nine-month sales of $37.5 million and net income of $719,000, or $0.14 per diluted share, from continuing operations.

Included in the 2007 third-quarter results are net sales of $2.0 million and net income of $89,000, or $0.02 per diluted share, from the acquisition of Tibbetts Industries. The nine-month period includes net sales of $2.9 million and net income of $37,000, or $0.01 per diluted share, from Tibbetts Industries.



Business Update

For the third quarter,IntriCons core businesses increased 60 percent year over year. The companys non-core electronics business decreased 3 percent from the third quarter of 2006. IntriCons gross margins rose to 28 percent from 23 percent a year earlier. Operating income more than doubled.



(more)

---

IntriCon Corporation 2007 Third-Quarter Results

October 24, 2007

Page 2



Said Gorder, By focusing on our expanding core businesses, were delivering significant incremental gains across the board. The Tibbetts acquisition enhances our medical and professional audio capabilities and product portfolio, and gives IntriCon a presence in the security market. Additionally, we recently entered into a strategic alliance with Minneapolis-based Advanced Medical Electronics Corp. (AME) to develop and manufacture new miniature, wireless, ultra low-power bio-telemetry instruments.

Through the agreement, IntriCon will manufacture AMEs bio-telemetry devices and supply them to third-party distributors. We also gain exclusive access to key AME technology and will be able to use this technology to develop additional bio-telemetry applications. Increasingly, the medical industry is looking for wireless, low-power capabilities in their devices, and we believe that AMEs technology will allow us to develop new devices that better connect patients and care givers, providing critical information and feedback.

Also in the third quarter, IntriCons Singapore facility achieved International Organization for Standardization (ISO) 13485 compliance. ISO 13485 compliance means that the companys Singapore plant meets the comprehensive management system requirements for the design and manufacture of medical devices.

Said Gorder, Achieving ISO 13485 compliance is a significant milestone for the company. It gives our key OEM customers a cost-effective way to manufacture their body-worn devices and other medical products. Being competitive in todays marketplace demands the ability to have manufacturing capabilities in lower-cost geographies. Going forward, we plan to expand into other cost-efficient locations.

In addition to possible overseas expansion, according to Gorder, IntriCons growth strategies may also include further acquisitions that are consistent with the companys mission. The company continues to work to accelerate new product development, further commit to research and development initiatives, and incorporate proprietary technology in all devices.

Concluded Gorder, As a company were delivering both sequential and year-over-year growth in our core businesses. While seasonality is a normal part of our industry, we believe that our long-term prospects in the miniature body-worn device arena are promising.







(more)

---

IntriCon Corporation 2007 Third-Quarter Results

October 24, 2007

Page 3



About IntriCon Corporation

Headquartered in Arden Hills, Minn., IntriCon Corporation designs, develops and manufactures miniature and micro-miniature body-worn medical and electronics products. The company is focused on four key markets: medical, hearing health, professional audio and communications, and electronics. IntriCon has facilities in the United States, Asia and Europe. The companys common stock trades under the symbol IIN on the American Stock Exchange. For more information about IntriCon, visitwww.intricon.com.



Forward-Looking Statements

Statements made in this release and in IntriCons other public filings and releases that are not historical facts or that include forward-looking terminology such as may, will, believe, expect, should, optimistic or continue or the negative thereof or other variations thereon are forward-looking statements within the meaning of the Securities Exchange Act of 1934 as amended. These forward-looking statements include, without limitation, statements concerning the benefits AMEs technology, prospects in the miniature body-worn device arena, future growth and expansion, future financial condition and performance, prospects, and the positioning of IntriCon to compete in chosen markets. These forward-looking statements are affected by known and unknown risks, uncertainties and other factors that are beyond
IntriCons control, and may cause IntriCons actual results, performance or achievements to differ materially from the results, performance and achievements expressed or implied in the forward-looking statements. These risks, uncertainties and factors include, without limitation, risks related to the Tibbetts acquisition, including unanticipated liabilities and expenses, the risk that IntriCon may not be able to achieve its long-term strategy, weakening demand for products of the company due to general economic conditions, possible non-performance of developing technological products, the volume and timing of orders received by the company, changes in the mix of products sold, competitive pricing pressures, availability of electronic components for the companys products, ability to create and market products in a timely manner, competition by competitors with more resources than the company, foreign currency risks arising from the companys foreign operations and
other risks detailed from time to time in the companys filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended December 31, 2006. The company disclaims any intent or obligation to publicly update or revise any forward-looking statements, regardless of whether new information becomes available, future developments occur or otherwise.



Contacts

At IntriCon:
        At Padilla Speer Beardsley:Scott Longval, CFO
        Matt Sullivan/Marian Briggs651-604-9526
        612-455-1700slongval@intricon.com
        msullivan@psbpr.com/mbriggs@psbpr.com




(more)

---

IntriCon Corporation 2007 Third-Quarter Results

October 24, 2007

Page 4



IntriCon Corporation

Consolidated Condensed Statements of Operations

(Unaudited)



Three Months EndedSeptember 30,2007
        
        September 30,2006Sales, net
        
        $
        18,441,894
        
        $
        12,487,832Costs of sales
        
        
        13,316,223
        
        
        9,614,058Gross profit
        
        
        5,125,671
        
        
        2,873,774Operating expenses:Selling expense
        
        
        1,094,340
        
        
        848,499General and administrative expense (a)
        
        
        2,167,118
        
        
        1,177,860Research and development expense
        
        
        734,778
        
        
        256,678Total operating expenses
        
        
        3,996,236
        
        
        2,283,037Operating income
        
        
        1,129,435
        
        
        590,737Interest expense
        
        
        (278,251
        )
        
        (91,394
        )Interest income
        
        
        13,265
        
        
        16,842Equity in earnings of partnerships
        
        
        (75,000
        )
        
        Other expense, net
        
        
        (53,444
        )
        
        (10,401
        )Income before income taxes
        
        
        736,005
        
        
        505,784Income tax expense
        
        
        85,545
        
        
        52,856Income from continuing operations
        
        
        650,460
        
        
        452,928Loss from discontinued operations, net of income tax expense
        
        
        
        
        
        (14,655
        )Net income
        
        $
        650,460
        
        $
        438,273Income (loss) per share:BasicContinuing operations
        
        $
        .13
        
        $
        .09Discontinued operations
        
        
        
        
        
        (.01
        )$
        .13
        
        $
        .08DilutedContinuing operations
        
        $
        .12
        
        $
        .08Discontinued operations
        
        
        
        
        
        (.00
        )$
        .12
        
        $
        .08Average shares outstanding:Basic
        
        
        5,201,966
        
        
        5,157,925Diluted
        
        
        5,562,345
        
        
        5,413,277




(a)
        General and administrative expense includes $66,488 and $56,166 of non-cash stock option expense related to the adoption of FAS 123(R) for 2007 and 2006, respectively.




(more)

---

IntriCon Corporation 2007 Third-Quarter Results

October 24, 2007

Page 5



IntriCon Corporation

Consolidated Condensed Statements of Operations

(Unaudited)



Nine Months EndedSeptember 30,2007
        
        September 30,2006Sales, net
        
        $
        49,958,858
        
        $
        37,532,457Costs of sales
        
        
        37,415,415
        
        
        28,372,969Gross profit
        
        
        12,543,443
        
        
        9,159,488Operating expenses:Selling expense
        
        
        2,899,978
        
        
        2,620,031General and administrative expense (a)
        
        
        5,200,599
        
        
        3,804,666Research and development expense
        
        
        2,118,236
        
        
        1,437,499Total operating expenses
        
        
        10,218,813
        
        
        7,862,196Operating income
        
        
        2,324,630
        
        
        1,297,292Interest expense
        
        
        (771,656
        )
        
        (392,570
        )Interest income
        
        
        71,048
        
        
        56,482Equity in earnings of partnerships
        
        
        (155,000
        )
        
        Other expense, net
        
        
        (43,394
        )
        
        (71,345
        )Income before income taxes
        
        
        1,425,628
        
        
        889,859Income tax expense
        
        
        220,816
        
        
        127,874Income from continuing operations
        
        
        1,204,812
        
        
        761,985Loss from discontinued operations, net of income tax expense
        
        
        
        
        
        (42,630
        )Net income
        
        $
        1,204,812
        
        $
        719,355Income (loss) per share:BasicContinuing operations
        
        $
        .23
        
        $
        .15Discontinued operations
        
        
        
        
        
        (.01
        )$
        .23
        
        $
        .14DilutedContinuing operations
        
        $
        .22
        
        $
        .14Discontinued operations
        
        
        
        
        
        (.01
        )$
        .22
        
        $
        .13Average shares outstanding:Basic
        
        
        5,197,071
        
        
        5,154,633Diluted
        
        
        5,466,128
        
        
        5,490,606




(a)
        General and administrative expense includes $208,187 and $149,512 of non-cash stock option expense related to the adoption of FAS 123(R) for 2007 and 2006, respectively.




(more)

---

IntriCon Corporation 2007 Third-Quarter Results

October 24, 2007

Page 6



IntriCon Corporation

Consolidated Condensed Balance Sheets

(Unaudited)



AssetsSeptember 30,2007
        
        December 31,2006(unaudited)Current assetsCash
        
        $
        1,022,869
        
        $
        599,459Restricted cash
        
        
        69,336
        
        
        60,158Accounts receivable, less allowance for doubtful accounts of $218,000 at 2007 and $246,000 at 2006
        
        
        9,200,046
        
        
        8,456,450Inventories
        
        
        10,273,165
        
        
        9,030,615Refundable income taxes
        
        
        30,951
        
        
        103,587Note receivable from sale of discontinued operations, less allowance of $225,000 at 2007 and 2006
        
        
        234,000
        
        
        300,000Other current assets
        
        
        687,750
        
        
        235,418Total current assets
        
        
        21,518,117
        
        
        18,785,687Property, plant and equipmentMachinery and equipment
        
        
        36,376,488
        
        
        28,767,904Less: accumulated depreciation
        
        
        28,118,423
        
        
        21,994,344Net property, plant and equipment
        
        
        8,258,065
        
        
        6,773,560Long-term note receivable from sale of discontinued operations
        
        
        
        
        
        75,000Goodwill
        
        
        8,147,623
        
        
        5,927,181Investment in partnerships
        
        
        1,558,925
        
        
        1,800,000Other assets, net
        
        
        1,454,638
        
        
        920,051$
        40,937,368
        
        $
        34,281,479










(more)

---

IntriCon Corporation 2007 Third-Quarter Results

October 24, 2007

Page 7



IntriCon Corporation

Consolidated Condensed Balance Sheets

(Unaudited)



Liabilities and Shareholders Equity
        
        September 30,2007
        
        December 31,2006(unaudited)Current liabilitiesChecks written in excess of cash
        
        $
        1,381,845
        
        $
        661,756Current maturities of long-term debt
        
        
        1,195,373
        
        
        952,730Accounts payable
        
        
        3,704,750
        
        
        5,161,450Income taxes payable
        
        
        150,230
        
        
        173,810Deferred gain on building sale
        
        
        110,084
        
        
        110,084Short-term partnership payable
        
        
        260,000
        
        
        260,000Other accrued liabilities
        
        
        4,060,566
        
        
        3,021,201Total current liabilities
        
        
        10,862,848
        
        
        10,341,031Long-term debt, less current maturities
        
        
        8,772,155
        
        
        3,830,461Other post-retirement benefit obligations
        
        
        951,175
        
        
        1,063,744Long-term partnership payable
        
        
        1,280,000
        
        
        1,280,000Note payable, net of current portion (Amecon)
        
        
        515,720
        
        
        515,720Deferred income taxes
        
        
        79,273
        
        
        79,273Accrued pension liability
        
        
        584,808
        
        
        628,569Deferred gain on building sale, net of current portion
        
        
        853,152
        
        
        935,715Total non-current liabilities
        
        
        13,036,283
        
        
        8,333,482Total liabilities
        
        
        23,899,131
        
        
        18,674,513Commitments and contingenciesShareholders equityCommon shares, $1 par; 10,000,000 shares authorized;5,722,975 and 5,706,235 shares issued; 5,207,221 and 5,190,481 outstanding
        
        
        5,722,975
        
        
        5,706,235Additional paid-in capital
        
        
        12,570,899
        
        
        12,339,988Accumulated earnings (deficit)
        
        
        215,307
        
        
        (989,505
        )Accumulated other comprehensive loss
        
        
        (205,866
        )
        
        (184,674
        )Less: 515,754 common shares held in treasury, at cost
        
        
        (1,265,078
        )
        
        (1,265,078
        )Total shareholders equity
        
        
        17,038,237
        
        
        15,606,966$
        40,937,368
        
        $
        34,281,479






# # #

---